Carl Zingmark
Overview
Explore the profile of Carl Zingmark including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lowenmark T, Kohn L, Kellgren T, Rosenbaum W, Bronnec V, Lofgren-Burstrom A, et al.
J Transl Med
. 2024 Oct;
22(1):947.
PMID: 39420333
Background: Mounting evidence suggests a significant role of the gut microbiota in the development and progression of colorectal cancer (CRC). In particular, an over-representation of oral pathogens has been linked...
2.
Nunes L, Li F, Wu M, Luo T, Hammarstrom K, Torell E, et al.
Nature
. 2024 Aug;
633(8028):137-146.
PMID: 39112715
Colorectal cancer is caused by a sequence of somatic genomic alterations affecting driver genes in core cancer pathways. Here, to understand the functional and prognostic impact of cancer-causing somatic mutations,...
3.
Edin S, Gylling B, Li X, Stenberg A, Lofgren-Burstrom A, Zingmark C, et al.
Br J Cancer
. 2023 Dec;
130(1):143-150.
PMID: 38040818
Background: The immune response has important clinical value in colorectal cancer (CRC) in both prognosis and response to immunotherapy. This study aims to explore tumour immune cell infiltration in relation...
4.
Kerdreux M, Edin S, Lowenmark T, Bronnec V, Lofgren-Burstrom A, Zingmark C, et al.
J Cancer
. 2023 Jun;
14(9):1479-1485.
PMID: 37325051
Microbiota dysbiosis may affect both the development and progression of colorectal cancer (CRC). Large metagenomic studies have highlighted specific oral bacteria linked to CRC including . Few studies have however...
5.
Lowenmark T, Lofgren-Burstrom A, Zingmark C, Ljuslinder I, Dahlberg M, Edin S, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497419
Increasing evidence suggests that the gut microbiota may impact colorectal cancer (CRC) development and progression. In this study, the tumour colonisation of two CRC-associated bacteria, and , was studied in...
6.
Boden S, Harbs J, Sundkvist A, Fuchs K, Myte R, Gylling B, et al.
Cancer Prev Res (Phila)
. 2022 Nov;
16(2):75-87.
PMID: 36367526
Prevention Relevance: The findings of this study do not support a major role for the metabolic gut hormones ghrelin and PYY in colorectal cancer development but suggest the possibility of...
7.
Lowenmark T, Li X, Lofgren-Burstrom A, Zingmark C, Ling A, Kellgren T, et al.
Cancer Immunol Immunother
. 2022 Mar;
71(10):2565-2575.
PMID: 35301576
The importance of the tumour microbiome in different aspects of colorectal cancer (CRC) has been increasingly recognised, but many questions remain. The aim of this study was to explore the...
8.
Li X, Larsson P, Ljuslinder I, Ling A, Lofgren-Burstrom A, Zingmark C, et al.
Pathol Res Pract
. 2021 Mar;
220:153379.
PMID: 33721619
Colorectal cancer (CRC) is a heterogeneous disease with different genetic and molecular backgrounds, leading to a diverse patient prognosis and treatment response. Four consensus molecular subtypes (CMS 1-4) have recently...
9.
Li X, Ling A, Kellgren T, Lundholm M, Lofgren-Burstrom A, Zingmark C, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33228141
The local anti-tumour immune response has important prognostic value in colorectal cancer (CRC). In the era of immunotherapy, a better understanding of the immune response in molecular subgroups of CRC...
10.
Lowenmark T, Lofgren-Burstrom A, Zingmark C, Eklof V, Dahlberg M, Nyunt Wai S, et al.
Sci Rep
. 2020 Sep;
10(1):15250.
PMID: 32943695
The use of faecal microbial markers as non-invasive biomarkers for colorectal cancer (CRC) has been suggested, but not fully elucidated. Here, we have evaluated the importance of Parvimonas micra as...